Guanlin Li Selected Research

Guanlin Li Research Topics

4	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2018
3	Hypoxia (Hypoxemia) 02/2022 - 10/2017
3	Infections 01/2022 - 10/2011
3	Anthrax 05/2013 - 03/2006
2	Ischemia 10/2022 - 01/2019
2	Neoplasms (Cancer) 10/2017 - 01/2014
1	Optic Nerve Injuries 10/2022
1	Glaucoma 10/2022
1	Retinal Diseases 10/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Postpartum Hemorrhage 01/2022
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Insulin Resistance 01/2019
1	Bacteremia 01/2019
1	Stomach Neoplasms (Stomach Cancer) 10/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2017
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2014
1	Plague (Bubonic Plague) 02/2008

4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2022 - 05/2013
3	VaccinesIBA 10/2008 - 03/2006
2	Phosphotransferases (Kinase)IBA 10/2017 - 01/2014
2	EpitopesIBA 10/2008 - 03/2006
1	Retinaldehyde (Retinal)IBA 10/2022
1	UbiquitinIBA 02/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Long Noncoding RNAIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2019
1	SuspensionsIBA 01/2019
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2019
1	JNK Mitogen-Activated Protein KinasesIBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	CD100 antigenIBA 11/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2018
1	LipopolysaccharidesIBA 01/2018
1	PhosphoproteinsIBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2017
1	AdrenomedullinIBA 10/2017
1	Small Interfering RNA (siRNA)IBA 10/2017
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	ponatinibIBA 01/2014
1	tyrosine receptor (receptor, tyrosine)IBA 01/2014
1	Virulence Factors (Pathogenicity Factors)IBA 05/2013
1	Interferon Type IIBA 10/2011
1	Neutralizing AntibodiesIBA 10/2008
1	aluminum sulfate (alum)IBA 10/2008
1	AntibodiesIBA 10/2008
1	anthrax toxin (anthrax lethal factor)IBA 10/2008

2	Therapeutics 10/2022 - 12/2020
1	Phage Therapy 12/2020